Neuropeptide control of ocular growth

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/22 (2006.01) A61K 38/17 (2006.01) C07K 14/575 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2075833

A method and medicaments for inhibition of abnormal postnatal ocular growth are disclosed. The method for inhibition of abnormal postnatal ocular growth comprises administering to the eye of an animal effective amount of VIP, PHI or analogue of these peptides. The medicaments of the invention comprise therapeutically effective amounts of a compound selected from the group consisting of vasoactive intestinal peptide, PHI and ocular growth inhibiting analogues of vasoactive intestinal peptide and PHI.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Neuropeptide control of ocular growth does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Neuropeptide control of ocular growth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neuropeptide control of ocular growth will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2090148

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.